Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael DeKlerk"'
Autor:
Anna Jonas, Victor Sumbi, Samson Mwinga, Michael DeKlerk, Francina Tjituka, Scott Penney, Michael R Jordan, Tiruneh Desta, Alice M Tang, Steven Y Hong
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e100539 (2014)
In response to concerns about the emergence of HIV drug resistance (HIVDR), the World Health Organization (WHO) has developed a comprehensive set of early warning indicators (EWIs) to monitor HIV drug resistance and good programme practice at antiret
Externí odkaz:
https://doaj.org/article/499c8a2237fa44db9919be7285543f46
Autor:
Anna Jonas, Justice Gweshe, Milner Siboleka, Michael Deklerk, Michael Gawanab, Alfons Badi, Victor Sumbi, Dawn Pereko, Abraham Blom, Samson Mwinga, Michael R Jordan, Logan Jerger, Kiger Lau, Steven Y Hong
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65653 (2013)
HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, therefore antiretroviral therapy (ART) program and site factors known to be associated with emergence of HIVDR should be monitored to optimize the quali
Externí odkaz:
https://doaj.org/article/ea45d305f9da44cd8889e31154e5a0f2
Autor:
Andreas N Shiningavamwe, Steven Y. Hong, Alfons Badi, Gillian Hunt, Kiger Lau, Heidi Sheehan, Michael R. Jordan, Andrew B. Trotter, Alice M. Tang, Johanna Ledwaba, Tiruneh Desta, Christine Wanke, Michael DeKlerk, Lynn Morris, Anna Jonas
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 68(4)
The World Health Organization (WHO) prospective surveys of acquired HIV drug resistance (HIVDR) evaluate HIVDR emerging after the first year of antiretroviral therapy (ART) and associated factors.Consecutive ART starters in 2009 were enrolled at 3 se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b87829a0f8b4983d3578faa7d302d52
https://pubmed.ncbi.nlm.nih.gov/25564107
https://pubmed.ncbi.nlm.nih.gov/25564107
Autor:
Michael DeKlerk, Milner Siboleka, Justice Gweshe, Alfons Badi, Michael Gawanab, Victor Sumbi, Anna Jonas, Kiger Lau, Samson Mwinga, Steven Y. Hong, Dawn Pereko, Michael R. Jordan, Logan Jerger, Abraham Blom
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 6, p e65653 (2013)
PLoS ONE, Vol 8, Iss 6, p e65653 (2013)
Background HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, therefore antiretroviral therapy (ART) program and site factors known to be associated with emergence of HIVDR should be monitored to optimiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c4ad3a7cb018f400979e0e4f3f8f03
https://pubmed.ncbi.nlm.nih.gov/23762406
https://pubmed.ncbi.nlm.nih.gov/23762406
Autor:
Steven Y. Hong, Francina Tjituka, Tiruneh Desta, Michael R. Jordan, Alice M. Tang, Victor Sumbi, Samson Mwinga, Michael DeKlerk, Anna Jonas, Scott Penney
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 7, p e100539 (2014)
PLoS ONE, Vol 9, Iss 7, p e100539 (2014)
Background In response to concerns about the emergence of HIV drug resistance (HIVDR), the World Health Organization (WHO) has developed a comprehensive set of early warning indicators (EWIs) to monitor HIV drug resistance and good programme practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f868d174ea1f6dc522532170326790ac
https://doi.org/10.1371/journal.pone.0100539
https://doi.org/10.1371/journal.pone.0100539